Moxibustion treatment for allergic rhinitis symptoms
The Therapeutic Effect and Standardization of Moxibustion in the Treatment of Allergic Rhinitis
This study is testing if moxibustion can help relieve symptoms of allergic rhinitis and is looking at different doses and treatment times to see what works best.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Henan University of Traditional Chinese Medicine Academic / other |
| Locations | 1 site (Zhengzhou) |
| Trial ID | NCT06173882 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of moxibustion in alleviating symptoms of allergic rhinitis. It will compare different doses and durations of moxibustion treatment to assess their impact on patient outcomes and body surface temperature. The study employs a randomized controlled design to ensure reliable results and aims to provide evidence-based recommendations for clinical practice in treating allergic rhinitis.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 75 who have been diagnosed with allergic rhinitis.
Not a fit: Patients with severe respiratory conditions, skin diseases, or those currently undergoing other treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from allergic rhinitis.
How similar studies have performed: While moxibustion has been used in traditional medicine, this specific approach and its rigorous evaluation in a controlled setting is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria * Those who meet the diagnostic criteria of Chinese and Western medicine for AR; * Age range from 18 to 75 years old, regardless of gender; * Patients and their families are informed and agree to the study. Exclusion criteria * Those who are undergoing other traditional Chinese medicine external treatment methods; * Those who have taken traditional Chinese medicine recently or during treatment; * Individuals who are allergic to heavy moxibustion smoke and dust; * Individuals with concomitant bronchial asthma or other respiratory system diseases; * Patients with severe skin diseases or ulcers in the local area where moxibustion is applied; * Pregnant and lactating patients; * Patients with severe diseases of important organs such as the heart, liver, lungs, and kidneys; * Those who are unable to receive treatment according to regulations due to inconvenience in work, study, transportation, or personal activities
Where this trial is running
Zhengzhou
- The First Affiliated Hospital of Henan University of Chinese Medicine — Zhengzhou, China (Recruiting)
Study contacts
- Study coordinator: Yang Xie, MD
- Email: xieyanghn@163.com
- Phone: 0371-66248624
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.